RegulyzeCaHMB
Calcium hydroxyl
CaHMB (Calcium hydroxyl) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 3-6 g/day max. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 3-6 g/day max | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About CaHMB
CaHMB is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Calcium hydroxyl). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is CaHMB permitted in nutraceuticals under FSSAI (India)?
CaHMB (Calcium hydroxyl) (listed in the regulation as “Calcium hydroxyl methyl butyrate (CaHMB)”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of CaHMB?
The permitted level recorded for CaHMB is 3-6 g/day max. Limits can vary by product type and market — confirm against the current regulation.
What product category does CaHMB belong to?
CaHMB is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of CaHMB?
CaHMB corresponds to Calcium hydroxyl.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.